Quick Answer
Odyssey Health, Inc. reported R&D Expense of $0.00 for fiscal year 2025.
Odyssey Health, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $55.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| April 30, 2025 | $0.00 | — | — |
| January 31, 2025 | $0.00 | -100.0% | — |
| October 31, 2024 | $0.00 | -100.0% | — |
| April 30, 2024 | $0.00 | — | -100.0% |
| January 31, 2024 | $42.8K | — | +85.9% |
| October 31, 2023 | $23.0K | — | -95.0% |
| January 31, 2022 | $460.7K | +981.0% | +42.9% |
| October 31, 2021 | $322.5K | — | +656.7% |
- Odyssey Health, Inc. showed a decrease of -100.0% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, Odyssey Health, Inc.’s r&d expense has declined by 100.0% (from $55.2 thousand to $0.00).
- The most recent figure is from Odyssey Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: